(Q73574820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

5 November 2019

main subject

0 references

author name string

M Vuoristo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Färkkilä

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Gylling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A L Karvonen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Leino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Lehtola

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Makinen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Mattila

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Tilvis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T A Miettinen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

136-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

NIH conference: Primary biliary cirrhosis: a model autoimmune disease

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Primary biliary cirrhosis: paradigm or paradox for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

A prospective trial of colchicine for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Apolipoprotein E in hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Gallstone cholesterol content is related to apolipoprotein E polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Apolipoprotein E polymorphism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Immunomodulatory effects of ursodeoxycholic acid on immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Impact of apo E phenotype on the regulation of cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980293-0

7 January 2021

10.1016/S0168-8278(97)80293-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9252087%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference